ZyVersa Therapeutics Reports Officer/Director Changes
Ticker: ZVSA · Form: 8-K · Filed: Dec 3, 2025 · CIK: 1859007
| Field | Detail |
|---|---|
| Company | Zyversa Therapeutics, Inc. (ZVSA) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance
TL;DR
ZyVersa Therapeutics is shuffling its execs and board members.
AI Summary
ZyVersa Therapeutics, Inc. filed an 8-K on December 3, 2025, reporting on the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also covers compensatory arrangements for certain officers. The company, formerly Larkspur Health Acquisition Corp., is incorporated in Delaware and based in Weston, Florida.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future company direction and performance.
Key Players & Entities
- ZyVersa Therapeutics, Inc. (company) — Registrant
- Larkspur Health Acquisition Corp. (company) — Former company name
- December 2, 2025 (date) — Date of earliest event reported
- December 3, 2025 (date) — Date of report
FAQ
What specific changes were made regarding directors or officers?
The filing indicates changes related to the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated December 2, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed as of December 3, 2025.
What was ZyVersa Therapeutics, Inc. formerly known as?
ZyVersa Therapeutics, Inc. was formerly known as Larkspur Health Acquisition Corp.
Where is ZyVersa Therapeutics, Inc. headquartered?
ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-12-03 16:15:26
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ZVSA (1) Indicate by ch
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-25-025966.txt ( ) — 196KB
- zvsa-20251202.xsd (EX-101.SCH) — 3KB
- zvsa-20251202_lab.xml (EX-101.LAB) — 33KB
- zvsa-20251202_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 3, 2025 ZYVERSA THERAPEUTICS, INC. /s/ Stephen Glover Stephen Glover Chief Executive Officer